Antiviral signaling protein MITA acts as a tumor suppressor in breast cancer by regulating NF-κB induced cell death

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 2, 2014, Pages 144-153

  Bhatelia, Khyati ^a   Singh, Aru ^b   Tomar, Dhanendra ^a   Singh, Kritarth ^a   Sripada, Lakshmi ^a   Chagtoo, Megha ^b   Prajapati, Paresh ^a   Singh, Rochika ^a   Godbole, Madan M ^b   Singh, Rajesh ^c  

^a Area Gandhinagar   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^c M S UNIVERSITY OF BARODA   (India)

Author keywords

Breast cancer; MITA; NF B; Tumor suppressor gene

Indexed keywords

ANTIVIRUS AGENT; CASPASE 8; DEATH RECEPTOR; ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEDIATOR OF IRF3 ACTIVATION PROTEIN; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER TISSUE; CARCINOGENESIS; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR SUPPRESSOR GENE;

BREAST CANCER; MITA; NF-ΚB; TUMOR SUPPRESSOR GENE;

BLOTTING, WESTERN; BREAST NEOPLASMS; CASPASES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MCF-7 CELLS; MEMBRANE PROTEINS; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS;

EID: 84890208102     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.11.006     Document Type: Article

References (39)

1. Nature 2012, 485:S49. (Suppl.).
2. Breast Cancer Facts and Figures 2006, American Breast Cancer Society.
3. Agarwal G., Pradeep P.V., Aggarwal V., Yip C.H., Cheung P.S. Spectrum of breast cancer in Asian women. World J. Surg. 2007, 31:1031-1040.
4. Agarwal G., Ramakant P. Breast cancer care in India: the current scenario and the challenges for the future. Breast Care (Basel) 2008, 3:21-27.
5. Breast Cancer Facts & Figures 2012, American Cancer Society.
6. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N., Schlemper R.J. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001, 345:784-789.
7. Weitzman S.A., Gordon L.I. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 1990, 76:655-663.
8. Pierce B.L., Ballard-Barbash R., Bernstein L., Baumgartner R.N., Neuhouser M.L., Wener M.H., Baumgartner K.B., Gilliland F.D., Sorensen B.E., McTiernan A., Ulrich C.M. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J. Clin. Oncol. 2009, 27:3437-3444.
9. Robertson F.M., Bondy M., Yang W., Yamauchi H., Wiggins S., Kamrudin S., Krishnamurthy S., Le-Petross H., Bidaut L., Player A.N., Barsky S.H., Woodward W.A., Buchholz T., Lucci A., Ueno N.T., Cristofanilli M. Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J. Clin. 2010, 60:351-375.
10. Lei Y., Moore C.B., Liesman R.M., O'Connor B.P., Bergstralh D.T., Chen Z.J., Pickles R.J., Ting J.P. MAVS-mediated apoptosis and its inhibition by viral proteins. PLoS One 2009, 4:e5466.
11. Ahn J., Gutman D., Saijo S., Barber G.N. STING manifests self DNA-dependent inflammatory disease. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:19386-19391.
12. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
13. Arnoult D., Soares F., Tattoli I., Girardin S.E. Mitochondria in innate immunity. EMBO Rep. 2011, 12:901-910.
14. R.E. Kingston, C.A. Chen, H. Okayama, Calcium phosphate transfection, Current protocols in cell biology/editorial board, Juan S. Bonifacino . . . [et al.], Chapter 20 (2003) Unit 20 23.
15. Tomar D., Sripada L., Prajapati P., Singh R., Singh A.K., Singh R. Nucleo-cytoplasmic trafficking of TRIM8, a novel oncogene, is involved in positive regulation of TNF induced NF-kappaB pathway. PLoS One 2012, 7:e48662.
16. Ketteler R., Sun Z., Kovacs K.F., He W.W., Seed B. A pathway sensor for genome-wide screens of intracellular proteolytic cleavage. Genome Biol. 2008, 9:R64.
17. Tomar D., Singh R., Singh A.K., Pandya C.D., Singh R. TRIM13 regulates ER stress induced autophagy and clonogenic ability of the cells. Biochim. Biophys. Acta 2012, 1823:316-326.
18. Chaitanya G.V., Steven A.J., Babu P.P. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun. Signal. CCS 2010, 8:31.
19. D'Amours D., Sallmann F.R., Dixit V.M., Poirier G.G. Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J. Cell Sci. 2001, 114:3771-3778.
20. O'Dea E., Hoffmann A. NF-kappaB signaling. Wiley Interdiscip. Rev. Syst. Biol. Med. 2009, 1:107-115.
21. Wang L., Du F., Wang X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 2008, 133:693-703.
22. Hasan M., Koch J., Rakheja D., Pattnaik A.K., Brugarolas J., Dozmorov I., Levine B., Wakeland E.K., Lee-Kirsch M.A., Yan N. Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes. Nat. Immunol. 2013, 14:61-71.
23. Abe T., Harashima A., Xia T., Konno H., Konno K., Morales A., Ahn J., Gutman D., Barber G.N. STING recognition of cytoplasmic DNA instigates cellular defense. Mol. Cell 2013, 50:5-15.
24. Ellinger J., Albers P., Muller S.C., von Ruecker A., Bastian P.J. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker. BJU Int. 2009, 104:48-52.
25. Schwarzenbach H., Hoon D.S., Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer 2011, 11:426-437.
26. Dawson S.J., Tsui D.W., Murtaza M., Biggs H., Rueda O.M., Chin S.F., Dunning M.J., Gale D., Forshew T., Mahler-Araujo B., Rajan S., Humphray S., Becq J., Halsall D., Wallis M., Bentley D., Caldas C., Rosenfeld N. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med. 2013, 368:1199-1209.
27. Chamilos G., Gregorio J., Meller S., Lande R., Kontoyiannis D.P., Modlin R.L., Gilliet M. Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37. Blood 2012, 120:3699-3707.
28. Shyu R.Y., Chang S.C., Yu J.C., Hsu S.J., Chou J.M., Lee M.S., Jiang S.Y. Expression and regulation of retinoid-inducible gene 1 (RIG1) in breast cancer. Anticancer Res. 2005, 25:2453-2460.
29. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., Sethi G. Inflammation and cancer: how hot is the link?. Biochem. Pharmacol. 2006, 72:1605-1621.
30. Yamamoto Y., Gaynor R.B. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 2001, 107:135-142.
31. Boehm J.S., Zhao J.J., Yao J., Kim S.Y., Firestein R., Dunn I.F., Sjostrom S.K., Garraway L.A., Weremowicz S., Richardson A.L., Greulich H., Stewart C.J., Mulvey L.A., Shen R.R., Ambrogio L., Hirozane-Kishikawa T., Hill D.E., Vidal M., Meyerson M., Grenier J.K., Hinkle G., Root D.E., Roberts T.M., Lander E.S., Polyak K., Hahn W.C. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 2007, 129:1065-1079.
32. Hutti J.E., Shen R.R., Abbott D.W., Zhou A.Y., Sprott K.M., Asara J.M., Hahn W.C., Cantley L.C. Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. Mol. Cell 2009, 34:461-472.
33. Parrondo R., de las Pozas A., Reiner T., Rai P., Perez-Stable C. NF-kappaB activation enhances cell death by antimitotic drugs in human prostate cancer cells. Mol. Cancer 2010, 9:182.
34. Ryan K.M., Ernst M.K., Rice N.R., Vousden K.H. Role of NF-kappaB in p53-mediated programmed cell death. Nature 2000, 404:892-897.
35. Englaro W., Bahadoran P., Bertolotto C., Busca R., Derijard B., Livolsi A., Peyron J.F., Ortonne J.P., Ballotti R. Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation. Oncogene 1999, 18:1553-1559.
36. Wajant H. The role of TNF in cancer. Results Probl. Cell Differ. 2009, 49:1-15.
37. Al-Zoubi M., Salem A.F., Martinez-Outschoorn U.E., Whitaker-Menezes D., Lamb R., Hulit J., Howell A., Gandara R., Sartini M., Arafat H., Bevilacqua G., Sotgia F., Lisanti M.P. Creating a tumor-resistant microenvironment: cell-mediated delivery of TNFalpha completely prevents breast cancer tumor formation in vivo. Cell Cycle 2013, 12:480-490.
38. Lopez J., John S.W., Tenev T., Rautureau G.J., Hinds M.G., Francalanci F., Wilson R., Broemer M., Santoro M.M., Day C.L., Meier P. CARD-mediated autoinhibition of cIAP1's E3 ligase activity suppresses cell proliferation and migration. Mol. Cell 2011, 42:569-583.
39. Torres V.A., Stupack D.G. Rab5 in the regulation of cell motility and invasion. Curr. Protein Pept. Sci. 2011, 12:43-51.